Skip to main content
    M

    Mirum Pharmaceuticals Inc (MIRM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $82.39
    +2.43 (+3.04%)

    Market Cap: $5.17B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    41%(12/29)
    Avg Surprise
    -70.34%

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.42
    Range$-0.53 - $-0.32
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$-0.70+39.5%
    60d ago$-0.70+39.5%
    30d ago$-0.69+38.0%
    7d ago$-0.69+38.0%
    Current$-0.42
    Revenue Consensus
    $178M
    Range$171M - $182M
    11 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-13.61
    Range$-13.61 - $-13.61
    1 analysts
    Revenue Consensus
    $199M
    Range$188M - $209M
    13 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-13.61---
    Sep 26EST
    		-$-0.42---
    Jun 26
    Reported Aug 5
    		$-0.80$-0.77-3.90%Miss-566.7%
    Mar 26
    Reported May 6
    		$-1.08$-0.35-208.57%Miss-260.0%
    Dec 25
    Reported Feb 25
    		$-0.12$-0.05-146.91%Miss+75.5%
    Sep 25
    Reported Nov 4
    		$0.05N/A+131.25%Beat+116.7%
    Jun 25
    Reported Aug 6
    		$-0.12N/A+63.64%Beat+76.9%
    Mar 25
    Reported May 7
    		$-0.30$-0.27-11.11%Miss+44.4%
    Dec 24
    Reported Feb 26
    		$-0.49$-0.25-98.70%Miss+25.8%
    Sep 24
    Reported Nov 12
    		$-0.30$-0.45+33.33%Beat+47.4%
    Jun 24
    Reported Aug 7
    		$-0.52$-0.46-13.04%Miss+20.0%
    Mar 24
    Reported May 8
    		$-0.54$-0.30-80.00%Miss+32.5%
    Dec 23
    Reported Feb 28
    		$-0.66$-0.24-175.00%Miss+33.3%
    Sep 23
    Reported Nov 2
    		$-0.57$-0.81+29.63%Beat+44.1%
    Jun 23
    Reported Aug 3
    		$-0.65$-0.79+17.72%Beat+22.6%
    Mar 23
    Reported May 4
    		$-0.80$-0.97+17.53%Beat+31.6%
    Dec 22
    Reported Mar 8
    		$-0.99$-1.02+2.94%Beat+40.4%
    Sep 22
    Reported Nov 9
    		$-1.02$-1.08+5.56%Beat+36.3%
    Jun 22
    Reported Aug 4
    		$-0.84$-1.06+20.75%Beat+42.1%
    Mar 22
    Reported May 5
    		$-1.17$-1.38+15.22%Beat+30.4%
    Dec 21
    Reported Mar 9
    		$-1.66$0.35-574.29%Miss-16.1%
    Sep 21
    Reported Nov 15
    		$-1.60$-1.50-6.67%Miss-86.0%
    Jun 21
    Reported Aug 5
    		$-1.45$-1.08-34.26%Miss-55.9%
    Mar 21
    Reported May 6
    		$-1.68$-0.98-71.43%Miss-95.3%
    Dec 20
    Reported Mar 9
    		$-1.43$-0.72-98.61%Miss-81.0%
    Sep 20
    Reported Nov 12
    		$-0.86$-0.98+12.24%Beat-2.4%
    Jun 20
    Reported Aug 6
    		$-0.93$-0.87-6.90%Miss+82.5%
    Mar 20
    Reported May 7
    		$-0.86$-0.84-2.38%Miss-44.5%
    Dec 19
    Reported Mar 12
    		$-0.79$-0.85+7.06%Beat-
    Sep 19
    Reported Nov 6
    		$-0.84$-0.63-33.33%Miss-
    Jun 19
    Reported Jul 25
    		$-5.31$-0.57-831.58%Miss-
    Mar 19
    Reported May 29
    		$-0.60$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-42.25EV/EBITDAN/A
    Price/FCF-22.83xFCF Yield-4.38%
    Profitability
    Profit Margin-139.20%Operating Margin-14.80%
    ROE-703.00%ROIC-116.00%
    Financial Health
    Debt/Equity-71.97xInterest Coverage-63.85x
    Current Ratio2.86xQuick Ratio2.74x
    Trading Statistics
    Beta0.61Avg Volume930.07K
    52-Week High$130.0052-Week Low$63.23

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$81.96
    SMA 20$85.41
    SMA 50$93.33
    SMA 200$98.51
    EMA 10$82.90
    EMA 20$85.71
    EMA 50$92.45
    EMA 200$93.48

    MACD

    Line: -3.94Signal: -4.12Hist: 0.18

    ADX

    ADX: 35.4+DI: 15.2-DI: 23.7

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down72.0
    PSAR$88.11

    Bollinger Bands

    Upper Band$94.06
    Lower Band$76.76
    %B Position2025%(Upper)
    Band Width0.33

    RSI (14-Day)

    Neutral
    39.5

    Momentum Oscillators

    Stoch %K21.4
    Stoch %D31.4
    Williams %R-65.8
    ROC (10d)-1.8%
    Momentum-1.53
    CCI (20d)-61.1
    MFI (14d)40.7

    Volatility Measures

    ATR (14d)$4.29(5.2%)
    StdDev (20d)4.32
    Hist Vol47.2%(High)

    Volume Flow

    VWAP$82.29
    OBV44.1M
    AD Line15.4M
    CMF (20d)-0.252

    Volume Metrics

    Avg Vol (20d)926.6K
    Vol Ratio0.7x
    VWMA (20d)$85.51

    Pivot Points

    R3$85.35
    R2$83.63
    R1$81.79
    Pivot Point$80.07
    S1$78.24
    S2$76.52
    S3$74.68

    Advanced Oscillators

    TSI-31.91
    Ultimate Osc46.4
    KST-144.70

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$176.24M$159.88M$148.93M$133.01M$127.78M$111.58M$99.41M$90.38M$77.88M$69.22M$69.55M$47.73M
    Cost of Revenue$30.35M$28.80M$28.26M$25.54M$23.42M$23.02M$22.78M$20.81M$20.23M$17.83M$25.02M$10.23M
    Gross Profit$145.90M$131.08M$120.67M$107.47M$104.36M$88.57M$76.63M$69.57M$57.65M$51.39M$44.53M$37.50M
    Operating Expenses$188.43M$920.54M$125.23M$104.87M$109.35M$103.75M$100.86M$82.25M$81.88M$77.86M$77.12M$62.65M
    R&D$106.96M$824.21M$51.11M$42.96M$46.07M$46.04M$44.03M$31.71M$32.67M$32.22M$30.93M$26.12M
    SG&A$81.47M$96.33M$74.13M$61.91M$63.29M$57.71M$56.83M$50.55M$49.21M$45.64M$46.18M$36.53M
    Operating Income$-42,537,000$-789,465,000$-4,567,000$2.60M$-4,989,000$-15,183,000$-24,222,000$-12,684,000$-24,232,000$-26,468,000$-32,585,000$-25,148,000
    Interest Income$3.85M$3.40M$3.42M$3.25M$3.03M$3.02M$3.20M$3.47M$3.49M$3.63M$3.77M$4.06M
    Interest Expense$2.62M$3.62M$3.60M$3.61M$3.59M$3.60M$3.58M$3.59M$3.57M$3.58M$3.56M$3.57M
    Income Before Tax$-65,538,000$-789,680,000$-4,963,000$2.64M$-5,459,000$-13,648,000$-24,366,000$-13,888,000$-24,003,000$-24,655,000$-35,434,000$-23,339,000
    Income Tax Expense$1.69M$475,000$767,000$-262,000$402,000$1.03M$-576,000$347,000$635,000$624,000$225,000$249,000
    Net Income$-67,227,000$-790,155,000$-5,730,000$2.90M$-5,861,000$-14,677,000$-23,790,000$-14,235,000$-24,638,000$-25,279,000$-35,659,000$-23,588,000
    EBITDA$-59,177,000$-782,137,000$1.73M$9.50M$1.58M$-6,590,000$-17,519,000$-7,292,000$-17,659,000$-18,633,000$-29,753,000$-20,753,000
    EBIT$-66,771,000$-789,465,000$-4,785,000$3.00M$-4,903,000$-13,075,000$-23,991,000$-13,771,000$-23,920,000$-24,711,000$-35,646,000$-23,826,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MIRM

    Government Contracts

    Gov Obligations (TTM)
    $1139
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    How Phase 3 Trial Success Will Impact Mirum Stock Investors

    Mirum Pharmaceuticals' recent Phase 3 EXPAND trial success for LIVMARLI, showing improved cholestatic itch and reduced bile acids in rare pediatric liver diseases like biliary atresia...

    Simply Wall Street•10/15/26•Bullish

    Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Mirum Pharmaceuticals announced inducement grants to 19 new employees, including Chief Medical Officer Rob Myers, M.D....

    Yahoo Finance•10/15/26•Neutral

    Form 4 Mirum Pharmaceuticals Inc: Robert Paul Myers (Chief Medical Officer) For: 9 October

    This article reports on a Form 4 filing from Mirum Pharmaceuticals Inc, detailing insider transactions by Robert Paul Myers, the Chief Medical Officer...

    Investing.com UK•10/15/26•Neutral

    Total non-current liabilities of Mirum Pharmaceuticals, Inc. – FWB:08D

    The article provides a financial data point for Mirum Pharmaceuticals, Inc. (FWB:08D), specifically focusing on its total non-current liabilities. It indicates that this financial data, along with other information...

    TradingView•10/14/26•Neutral

    Medical chief receives 40,000 options and a 25,000-share stock grant at Mirum Pharmaceuticals (MIRM).

    Mirum Pharmaceuticals' Chief Medical Officer, Robert Paul Myers, was granted 40,000 employee stock options with an exercise price of $86.01 and 25,000 restricted stock units on October 9...

    Stock Titan•10/14/26•Neutral

    MIRM Valuation and Fair Value

    P/E
    -42.3x
    Forward P/E
    166.7x
    P/FCF
    -22.8x
    P/B
    -501.0x
    See GNG's fair value

    MIRM Profitability: Margins, ROIC and FCF

    Gross margin
    81.7%
    Operating margin
    -14.8%
    Net margin
    -139.2%
    ROIC
    -116.0%
    ROE
    -703.0%
    FCF margin
    -37.0%
    FCF yield
    -4.4%

    MIRM Competitors

    CompanyTicker
    Merit Medical Systems IncMMSI
    Waystar Holding Corp. Common StockWAY
    Teleflex IncorporatedTFX
    Erasca IncERAS
    Stevanato Group SpASTVN
    Oruka Therapeutics, Inc.ORKA
    RadNet IncRDNT
    Sotera Health CoSHC

    Sector: Healthcare

    MIRM Analyst Ratings

    Consensus
    Buy
    Analysts
    14
    Strong Buy
    4
    Buy
    10
    Hold
    0
    Sell
    0
    Strong Sell
    0

    MIRM Bull Case vs Bear Case

    Bull case

    • MIRM grew quarterly revenue 37.9% year over year.
    • 100.0% of MIRM's analyst ratings are Buy or Strong Buy.

    Bear case

    • MIRM has a -139.2% net profit margin.
    • MIRM beat EPS estimates in 37.5% of its last 8 reported quarters.

    MIRM Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -30.1%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.42
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About MIRM

    Does MIRM pay dividends?

    Mirum Pharmaceuticals Inc (MIRM) does not currently pay a regular dividend.

    What is MIRM's market cap?

    Mirum Pharmaceuticals Inc (MIRM) has a market capitalization of $5.17B with a current stock price of $82.39.

    Related stocks

    Sector: Healthcare

    All stocks starting with M

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In